v3.26.1
Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (17,606,382) $ (5,537,069)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 182,823 499,887
Change in fair value of warrants (268,000) (558,000)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (475,335) (1,127,361)
Accounts payable 2,685,152 (935,785)
Accrued expenses 6,470,118 (440,836)
Net cash used in operating activities (9,011,624) (8,099,164)
Cash flows from financing activities:    
Proceeds from issuance of common stock, and warrants, net 3,698,367 19,783,423
Net cash provided by financing activities 3,698,367 19,783,423
Net (decrease) increase in cash and cash equivalents (5,313,257) 11,684,259
Cash and cash equivalents, beginning of period 19,532,338 10,551,916
Cash and cash equivalents, end of period $ 14,219,081 $ 22,236,175